PubRank

Martina Dören

Author PubWeight™ 28.85‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Cohort profile: the study of health in Pomerania. Int J Epidemiol 2010 4.38
2 Menopausal hormone therapy and risk of breast cancer: a meta-analysis of epidemiological studies and randomized controlled trials. Hum Reprod Update 2005 1.18
3 The impact of the Women's Health Initiative Randomized Controlled Trial 2002 on perceived risk communication and use of postmenopausal hormone therapy in Germany. Menopause 2005 1.12
4 Menopausal status and hepatic steatosis in a general female population. Gut 2007 1.11
5 Menopausal hormone therapy and risk of lung cancer-Systematic review and meta-analysis. Maturitas 2009 1.08
6 Gender-dependent associations between socioeconomic status and tooth loss in working age people in the Study of Health in Pomerania (SHIP), Germany. Community Dent Oral Epidemiol 2011 0.98
7 The role of physical activity in the prevention of osteoporosis in postmenopausal women-An update. Maturitas 2009 0.98
8 Menopausal hormone therapy and risk of ovarian cancer: systematic review and meta-analysis. Hum Reprod Update 2007 0.96
9 Gender differences in the relation between number of teeth and systolic blood pressure. J Hypertens 2006 0.93
10 Menopause and determinants of quality of life in women at midlife and beyond: the study of health in pomerania (SHIP). Menopause 2007 0.89
11 [Psychosocial risk factors for cancer development]. Med Klin (Munich) 2007 0.89
12 Results from WHI and HERS II--implications for women and the prescriber of HRT. Maturitas 2002 0.86
13 Physical activity and postmenopausal health. J Br Menopause Soc 2004 0.86
14 Differences in menopausal hormone therapy use among women in Germany between 1998 and 2003. BMC Womens Health 2007 0.85
15 Hormonal contraceptive use among adolescent girls in Germany in relation to health behavior and biological cardiovascular risk factors. J Adolesc Health 2011 0.81
16 Socioeconomic indicators and prosthetic replacement of missing teeth in a working-age population--results of the Study of Health in Pomerania (SHIP). Community Dent Oral Epidemiol 2009 0.80
17 Hormone therapy in perimenopause and postmenopause (HT). Interdisciplinary S3 Guideline, Association of the Scientific Medical Societies in Germany AWMF 015/062-short version. Arch Gynecol Obstet 2011 0.80
18 Inverse association between number of teeth and left ventricular mass in women. J Hypertens 2007 0.79
19 Association between hormone replacement therapy and subsequent arterial and venous vascular events: a meta-analysis. Eur Heart J 2009 0.77
20 Menopausal hormone therapy does not play a major role in left ventricular hypertrophy. Maturitas 2010 0.77
21 Cognitive function and menopausal hormone therapy. Hum Reprod Update 2007 0.76
22 Re: "Reproductive hormone exposure timing and ischemic heart disease: complicated answers to a simple question" by Merz et al. [Maturitas 65 (2010) 297-298]. Maturitas 2010 0.75
23 Postmenopausal hormone therapy in clinical perspective. Menopause 2008 0.75
24 Efficacy unproven. Dtsch Arztebl Int 2008 0.75
25 Re: Risk of different histological types of postmenopausal breast cancer by type and regimen of menopausal hormone therapy. Int J Cancer 2009 0.75
26 Re: "invited commentary: Hormone therapy and risk of coronary heart disease--why renew the focus on the early years of menopause?". Am J Epidemiol 2007 0.75
27 Re: Louwman WJ et al. On the rising trends of incidence and prognosis for breast cancer patients diagnosed 1975-2004: a long-term population-based study in southeastern Netherlands. Cancer Causes Control 19:97-106. Cancer Causes Control 2008 0.75
28 Re: The special extract ERr 731 of the roots of Rheum rhaponticum decreases anxiety and improves health state and general well-being in perimenopausal women. Menopause 2007 0.75
29 Hospital mortality in acute myocardial infarction. JAMA 2010 0.75
30 Efficacy, safety, tolerability, and potential adverse effects of low-dose oral continuous combined menopausal hormone therapies, mostly double-blind clinical trials lasting for at least 2 years. Maturitas 2007 0.75
31 [Endocrinology--I]. Med Klin (Munich) 2004 0.75
32 [Endocrinology. II]. Med Klin (Munich) 2004 0.75
33 [Communication about incontinence between affected individuals and health care providers - the patients' perspective]. Z Gerontol Geriatr 2008 0.75
34 Critical comments. Maturitas 2003 0.75
35 Correspondence (letter to the editor): Death Risk of Younger Women Does Not Differ Significantly From That of Older Women. Dtsch Arztebl Int 2008 0.75
36 [Hormone therapy with climacteric--what remains?]. Med Monatsschr Pharm 2004 0.75